Law firm Blank Rome has expanded its litigation department with the appointment of life science specialist and partner Gary Ruckelshaus.
Biopharmaceutical company Opexa Therapeutics has expanded its IP portfolio to include nearly 100 validated patents worldwide, the company has said.
Healthcare advocate Médecins Sans Frontières has urged Indian Prime Minister Narendra Modi not to change IP laws which allow for the production of generic medicines.
Research organisation Horizon Discovery Group has bought Sage Labs in a deal worth almost $50 million, a move that will strengthen its IP portfolio, the company has announced.
A trade deal between the EU and Canada, due to be signed today if last-minute German concerns can be overcome, would have implications for pharmaceutical IP protection and could raise the cost of drugs in Canada, a report has claimed.
A US court has ordered medical technology company Boston Scientific Corporation to pay $309 million to the family of the late physician Michel Mirowski in the latest chapter of their long running patent dispute.
Law firm Miller, Canfield, Paddock & Stone has expanded its IP team in China with the appointment of life sciences specialist Kening Li.
Generic drug maker Par Pharmaceutical Companies has settled a long running dispute with Salix Pharmaceuticals over its heartburn drug Zegerid (omeprazole/sodium bicarbonate).
UK-based cancer drug company Sareum has been granted a patent for an invention forming part of its treatment methods.